| Bioactivity | Aurantiamide acetate (TMC-58A) is a selective and orally active cathepsin inhibitor isolated from Portulaca oleracea L. Aurantiamide acetate has anti-inflammatory activities and can be used for the study of inflammatory diseases[1][2]. | ||||||||||||
| Invitro | Aurantiamide acetate inhibits cathepsin L (3.4.22.15) and cathepsin B (3.4.22.1) with IC50 of 12 μM and 49 μM, respectiveiy[1]. | ||||||||||||
| Name | Aurantiamide acetate | ||||||||||||
| CAS | 56121-42-7 | ||||||||||||
| Formula | C27H28N2O4 | ||||||||||||
| Molar Mass | 444.52 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Aurantiamide acetate
CAS: 56121-42-7 F: C27H28N2O4 W: 444.52
Aurantiamide acetate (TMC-58A) is a selective and orally active cathepsininhibitor isolated from Portulaca olerace
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.